Endoscopic Disease Activity and Biologic Therapy Are Independent Predictors of Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy

被引：0
|
作者：
Anand Kumar
Vinayak Shenoy
Megan C. Buckley
Laura Durbin
James Mackey
Anjali Mone
Arun Swaminath
机构：
[1] Lenox Hill Hospital,Division of Gastroenterology
[2] Donald and Barbara Zucker School of Medicine at Hofstra/Northwell,Feinstein Institutes for Medical Research
[3] Institute of Health System Science,undefined
来源：
Digestive Diseases and Sciences | 2022年 / 67卷
关键词：
Inflammatory bowel disease; Colonoscopy; Bowel preparation quality; Disease activity; Biologic therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4851 / 4865
页数：14
相关论文
共 50 条
  • [41] Dual biologic therapy in pediatric Inflammatory Bowel Disease
    Abbas, R.
    Ibrahim, N.
    Elawad, M.
    Al-Mudahka, F.
    Abdelrhman, H.
    Akobeng, A. K.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 747 - 747
  • [42] Evolutionary biologic therapy for inflammatory bowel disease.
    Hanauer S.B.
    Current Gastroenterology Reports, 1999, 1 (6) : 467 - 469
  • [43] Identifying Independent Predictors of Hospital Readmission in Patients With Inflammatory Bowel Disease
    Kunkle, Bryce
    Singh, Harjit
    Mattar, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S865 - S866
  • [44] Predictors of bowel preparation quality in patients undergoing colonoscopy - a preliminary analysis
    Thabane, Marmon
    Chauhan, Nita
    Chauhan, Usha
    Tse, Frances
    Dahab, Salim T.
    Wolfe, Melanie A.
    Armstrong, David
    GASTROENTEROLOGY, 2008, 134 (04) : A319 - A319
  • [45] Higher Sedation Requirements Among Inflammatory Bowel Disease Patients Undergoing Colonoscopy for Disease Activity Assessment or Dysplasia Surveillance
    Weber, Andrew T.
    Ather, Nimah
    Tran, Vivy
    Sauk, Jenny
    Ha, Christina
    CROHNS & COLITIS 360, 2019, 1 (01)
  • [46] Assessment of predictors of the need for biologic therapy in patients with inflammatory bowel disease: a single tertiary centre experience
    Raimundo Fernandes, S.
    Correia, L.
    Santos, P. Moura
    Rita Goncalves, A.
    Valente, A.
    Baldaia, C.
    Velosa, J.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S415 - S415
  • [47] Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease
    Shah, Nisha B.
    Zuckerman, Autumn D.
    Hosteng, Katie R.
    Fann, Jessica
    Declercq, Josh
    Choi, Leena
    Cherry, Laura
    Schwartz, David A.
    Horst, Sara
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (12) : 4331 - 4338
  • [48] Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease
    Nisha B. Shah
    Autumn D. Zuckerman
    Katie R. Hosteng
    Jessica Fann
    Josh DeClercq
    Leena Choi
    Laura Cherry
    David A. Schwartz
    Sara Horst
    Digestive Diseases and Sciences, 2023, 68 : 4331 - 4338
  • [49] Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study
    Zissimopoulos, Athanasios
    Vradelis, Stergios
    Konialis, Manolis
    Chadolias, Dimitrios
    Bampali, Asimenia
    Constantinidis, Theodoros
    Efremidou, Eleni
    Kouklakis, George
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (08) : 942 - 949
  • [50] Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study
    Vradelis, Stergios
    Kouklakis, George
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (11) : 1397 - 1397
12345